Celgene's billion-dollar bet, the future of Zoetis, and gentrification in biotech | File Type: audio/mpeg | Duration: 20:21
Celgene's billion-dollar bet, the future of Zoetis, and gentrification in biotech
Shopping for GSK, becoming Allergan, and turning $5M into $315M | File Type: audio/mpeg | Duration: 23:44
Shopping for GSK, becoming Allergan, and turning $5M into $315M
FierceBiotech Radio at #BIO2015, Part II | File Type: audio/mpeg | Duration: 24:05
FierceBiotech Radio at #BIO2015, Part II
FierceBiotech Radio at #BIO2015, Part I | File Type: audio/mpeg | Duration: 01:01:54
FierceBiotech Radio at #BIO2015, Part I
Teva, Mylan, biotech insider trading and the 'female Viagra' saga | File Type: audio/mpeg | Duration: 32:38
Teva, Mylan, biotech insider trading and the 'female Viagra' saga
FierceBiotech Radio at the Battle of the Biotech Bands | File Type: audio/mpeg | Duration: 09:12
FierceBiotech Radio at the Battle of the Biotech Bands
FierceBiotech Radio with Editas Medicine's Katrine Bosley | File Type: audio/mpeg | Duration: 29:56
FierceBiotech Radio with Editas Medicine's Katrine Bosley
J&J's Ken Drazan on changing winds in R&D and biotech's boom | File Type: audio/mpeg | Duration: 21:07
J&J's Ken Drazan on changing winds in R&D and biotech's boom
Is biotech in a bubble? And which drug name will win the #FierceMadness tournament? | File Type: audio/mpeg | Duration: 29:14
Is biotech in a bubble? And which drug name will win the #FierceMadness tournament?
FierceBiotech Radio and EP Vantage on biotech's big 2014 | File Type: audio/mpeg | Duration: 25:14
FierceBiotech Radio and EP Vantage on biotech's big 2014
FierceBiotech Radio with Express Scripts' Steve Miller | File Type: audio/mpeg | Duration: 17:01
FierceBiotech Radio with Express Scripts' Steve Miller
FierceBiotech Radio with Carol Gallagher | File Type: audio/mpeg | Duration: 32:01
FierceBiotech Radio with Carol Gallagher
FierceBiotech Radio with Michael Gilman | File Type: audio/mpeg | Duration: 33:06
FierceBiotech Radio with Michael Gilman
